Spotlight On ATTR-CM
Welcome to Spotlight On ATTR-CM, your go-to source for the latest research, diagnostic advancements, and therapeutic strategies in transthyretin amyloid cardiomyopathy (ATTR-CM). Join leading cardiologists and researchers as they share their insights on this intricate condition to enhance patient care and outcomes.
Improving ATTR-CM Care Through Community-Specialist Partnership
Heart MattersImproving ATTR-CM Care Through Community-Specialist Partnership
Alex Reyentovich, MD
Recognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Heart MattersRecognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Exploring Deeper Silencing in Transthyretin Amyloidosis
AudioAbstractsExploring Deeper Silencing in Transthyretin Amyloidosis
Ryan Quigley
How Symptoms Shape Caregiver Burden in ATTR-CM
AudioAbstractsHow Symptoms Shape Caregiver Burden in ATTR-CM
Ryan Quigley
Ronald Witteles, MD
Assessing Stroke Risk in ATTR-CM with Atrial Mechanics
Heart MattersAssessing Stroke Risk in ATTR-CM with Atrial Mechanics
The Limits of Traditional AFib Prediction Models in ATTR-CA
Heart MattersThe Limits of Traditional AFib Prediction Models in ATTR-CA
Quality of Life Conversations in ATTR-CM Care
Heart MattersQuality of Life Conversations in ATTR-CM Care
Kevin S. Shah, MD
Supporting Patients With ATTR-CM: Preserving Function and Quality of Life
Heart MattersSupporting Patients With ATTR-CM: Preserving Function and Quality of Life
Joban Vaishnav, MD
Counseling Patients on Disease Progression in ATTR-CM
Heart MattersCounseling Patients on Disease Progression in ATTR-CM
Joban Vaishnav, MD
Rethinking Thromboembolic Risk in ATTR-CM Care
Heart MattersRethinking Thromboembolic Risk in ATTR-CM Care
- advertisement
Tafamidis Evidence in ATTR-CM: What Holds Up in Practice
Spotlight On ATTR-CMTafamidis Evidence in ATTR-CM: What Holds Up in Practice
ATTR-CM Patient Education and Shared Decision-Making
Spotlight On ATTR-CMATTR-CM Patient Education and Shared Decision-Making
ATTR-CM Palliative Care and Advance Care Planning
Spotlight On ATTR-CMATTR-CM Palliative Care and Advance Care Planning
ATTR-CM Endomyocardial Biopsy and Histology
Spotlight On ATTR-CMATTR-CM Endomyocardial Biopsy and Histology
Monitoring Protocols in ATTR-CM: Follow Trends, Not Single Signals
Spotlight On ATTR-CMMonitoring Protocols in ATTR-CM: Follow Trends, Not Single Signals
ATTR-CM Staging and Risk Stratification: NAC, Mayo, NYHA
Spotlight On ATTR-CMATTR-CM Staging and Risk Stratification: NAC, Mayo, NYHA
ATTR-CM Arrhythmia Management and Heart Failure Co-Management
Spotlight On ATTR-CMATTR-CM Arrhythmia Management and Heart Failure Co-Management
ATTR-CM Gene Silencers: Patisiran, Eplontersen, and Combination Therapy
Spotlight On ATTR-CMATTR-CM Gene Silencers: Patisiran, Eplontersen, and Combination Therapy
ATTR-CM: A Progressive Amyloid Heart Failure Syndrome
Spotlight On ATTR-CMATTR-CM: A Progressive Amyloid Heart Failure Syndrome
Case-Based Framing in ATTR-CM: When Suspicion Becomes a Treatment Decision
Spotlight On ATTR-CMCase-Based Framing in ATTR-CM: When Suspicion Becomes a Treatment Decision
ATTR-CM Red Flags: Cardiac and Extracardiac Clues
Spotlight On ATTR-CMATTR-CM Red Flags: Cardiac and Extracardiac Clues
ATTRv vs ATTRwt: Hereditary and Wild-Type ATTR-CM
Spotlight On ATTR-CMATTRv vs ATTRwt: Hereditary and Wild-Type ATTR-CM
- advertisement